Good results seen with NRTI-sparing regimens of atazanavir plus newer drug classes
Prevention strategies need to target both early and chronic HIV infection
CASCADE analysis finds antiretroviral treatment benefits are evident below CD4 count of 500, uncertain above this level
Second-ever pre-exposure prophylaxis study reports no safety concerns and promising result
UK: one in six gay men testing HIV-positive were infected recently
Penal reform, decriminalisation of illicit drugs, and increased advocacy all central to improving prisoners' health
Starting ART two weeks after TB treatment reduces death risk by one-third in people with HIV
